Our findings suggest that Asperglaucide may inhibit tumor development by interacting with CCND1 to regulate key signaling pathways, including the AGE-RAGE signaling pathway, the PI3K-Akt signaling pathway, and the AMPK signaling pathway. This evidence concerns the gene CCND1 and neoplasm.